GitLife Biotech is at the forefront of synthetic biology, offering groundbreaking solutions that enhance the integrity and traceability of biological assets. Specialising in engineering biology, cell engineering, DNA barcoding, and comprehensive biological asset management, GitLife technology aligns with the objective of facilitating transparency essential for future advancements of engineering biology and intellectual property right management.
Overview of Synthetic Biology
What is Synthetic Biology?
Synthetic biology combines biology with engineering. It involves redesigning organisms for useful purposes by engineering them to have new abilities. This innovative approach allows scientists to create biological systems and devices that do not exist in the natural world.
Applications of Synthetic Biology
Synthetic biology has a wide range of applications, from healthcare and life science to environmental protection and bioenergy. It enables the development of new therapeutics, biofuels, and sustainable agricultural practices. The ability to engineer organisms at a genetic level opens up possibilities for solving some of the world’s most pressing challenges.
The GitLife Biotech Mission: Enabling the Potential of Synthetic Biology
Mission
To set the global standard in the management of integrity, provenance
and attribution as well as biosafety and biosecurity of biological assets.
CellRepo®: Genetic Engineering with Version Control
CellRepo® is our revolutionary platform that brings version control to cell engineering. Originating from software engineering, this system meticulously logs each modification to microbial strains. Utilising our proprietary GenoSegnature® technology, every change is recorded and retrievable, facilitating more effective strain development. This ensures complete traceability and management of biological assets and provides a detailed history of genetic modifications, enhancing transparency and reliability in synthetic biology.
DNA GenoSegnature®
Traceability, transparency, and ultimately trustworthiness are required from cradle to grave for engineered cell lines. With our proprietary DNA GenoSegnature® we will ensure the absolute integrity of biological assets – proof of provenance, proof of ownership, with clear records of origin and robust traceability.
Our revolutionary biosecurity technologies will allow scientists to see what a strain is, if anyone owns it, who constructed it and how. Will be of huge potential value to any engineering biology and industrial biotech organisation seeking to protect and commercialise their assets.
Biological Asset Management
At GitLife Biotech we provide comprehensive biological asset management services, ensuring the provenance and integrity of genetic materials. This includes the use of CellRepo® version control and DNA GenoSegnature ® to manage and document biological assets accurately, allowing for enhanced strain development and cell engineering processes.
The Future of Synthetic Biology
Emerging Trends
The field of synthetic biology is rapidly evolving, with new trends and technologies emerging. GitLife Biotech is at the forefront of these developments, driving innovation and setting new standards in genetic engineering and biological asset management.
Potential Impact on Healthcare
Synthetic biology holds the potential to transform healthcare by enabling the development of novel therapeutics and treatments. GitLife Biotech is dedicated to exploring these possibilities and contributing to the advancement of healthcare solutions.
